On Thursday, New York Attorney General Letitia James and 41 other state AGs resolved the transvaginal mesh lawsuit involving J&J (Johnson & Johnson) and their subsidiary Ethicon, Inc. for $117 million.
The defendants were facing allegations for hiding the risks associated with its pelvic mesh products, which support women's weakening pelvic organs. The court papers further stated that the companies should now impart the irreversible risks including, chronic pain, inflammation, incontinence, painful sex, and scarring. The defendants are also barred from telling about its FDA approval, which was initially done in 2002, and now has been told to stop selling “due to safety concerns.”
Around four million women have vaginal mesh implants, and more than 150,000 developed complications associated with it. There are in all 7 MDLs to handle Transvaginal Mesh Litigations, which are being overseen by U.S. District Judge Joseph R. Goodwin.
